RUO

Published

Also known as: Research Use Only, research use only

Research Use Only — a regulatory designation meaning the tool provides research scores, not clinical diagnoses. The same label used by REVEL, CADD, AlphaMissense, and PolyPhen-2.

Source: FDA 21 CFR 809.10(c)(2) — labeling requirements for Research Use Only products. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-809/subpart-B/section-809.10

Primary reference ↗

Research Use Only (RUO) is a regulatory designation for products intended for research applications, not for use in clinical diagnosis or treatment decisions. RUO products are not FDA-cleared or approved as diagnostic devices.

What It Means in Practice

An RUO designation means:

  • The tool provides computational evidence to support research
  • Clinical laboratories may use RUO scores within their own validated workflows (as part of a laboratory-developed test, or LDT)
  • The responsibility for clinical validation lies with the laboratory, not the tool developer

Precedent: Established Computational Variant Predictors

Major computational variant effect predictors are all RUO:

ToolRUOACMG Evidence Code
REVELYesPP3/BP4
CADDYesPP3/BP4
AlphaMissenseYesPP3/BP4
PolyPhen-2YesPP3/BP4
SIFTYesBP4
ESM-2 (NeuroAutomata)YesPP3/BP4

These tools contribute ACMG evidence criteria PP3 (computational evidence pathogenic) and BP4 (computational evidence benign) when incorporated into a clinical variant classification workflow.

RUO Is Not a Limitation

RUO does not mean the tool is unvalidated or unreliable. It means the tool is positioned appropriately within the clinical evidence hierarchy. The DMS validation benchmarks in the ESM-2 Benchmark Series document exactly where and how well the scores perform — which is what clinical labs need to assess before incorporating any computational tool.